Stay updated with breaking news from Ed Arce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Operator: Welcome to the AcelRx third quarter 2023 financial results conference call.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Universal Health (UHS – Research Report), Vik...
In a report released today, Ed Arce from H.C. Wainwright maintained Inventiva (IVA – Research Report) to a Buy, with a price target of $36...
Keybanc cut the price target for Danaher Corporation (NYSE: DHR) from $325 to $300. Keybanc analyst Paul Knight maintained an Overweight rating. Danaher shares rose 0.6% to $248.75 in pre-market trading.